Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | February 15, 2023 09:05am

Gainers

  • TransCode Therapeutics (NASDAQ:RNAZ) shares rose 95.7% to $0.92 during Wednesday's pre-market session. The company's market cap stands at $11.9 million.
  • Tenon Medical (NASDAQ:TNON) shares rose 75.75% to $1.74. The market value of their outstanding shares is at $19.5 million.
  • Humanigen (NASDAQ:HGEN) shares rose 22.16% to $0.22. The market value of their outstanding shares is at $26.1 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) shares increased by 21.51% to $0.79. The market value of their outstanding shares is at $10.6 million.
  • OraSure Technologies (NASDAQ:OSUR) stock rose 17.88% to $5.81. The market value of their outstanding shares is at $422.0 million. As per the news, the Q4 earnings report came out yesterday.
  • BioSig Technologies (NASDAQ:BSGM) stock moved upwards by 14.16% to $1.37. The market value of their outstanding shares is at $80.8 million.

Losers

  • T2 Biosystems (NASDAQ:TTOO) shares declined by 25.9% to $0.8 during Wednesday's pre-market session. The company's market cap stands at $5.8 million.
  • Aclarion (NASDAQ:ACON) stock declined by 12.23% to $0.7. The market value of their outstanding shares is at $5.4 million.
  • Blue Water Vaccines (NASDAQ:BWV) shares fell 8.98% to $1.42. The company's market cap stands at $21.9 million.
  • Lixte Biotech Hldgs (NASDAQ:LIXT) stock fell 8.47% to $1.08. The company's market cap stands at $17.9 million.
  • OncoCyte (NASDAQ:OCX) stock declined by 8.14% to $0.4. The market value of their outstanding shares is at $46.8 million.
  • Rubius Therapeutics (NASDAQ:RUBY) shares declined by 8.0% to $0.16. The market value of their outstanding shares is at $14.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON BSGM BWV HGEN LIXT OCX OSUR RNAZ RUBY TNON TTOO VLON

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist